# Adapalene

## Differin gel 0.1%, 15gm

| TAH Drug Code      | [**EDIFF**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EDIFF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of acne vulgaris.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Acne vulgaris Apply once daily in the evening before bedtime.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to adapalene or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | >10%: Dermatologic: Xeroderma (<=45%), exfoliation of skin (<=44%), erythema (<=38%), burning sensation of skin (<=29%), stinging of the skin (<=29%) 1% to 10%: Dermatologic: Skin abnormalities (1% to 6%; discomfort), desquamation (2%), pruritus (<=2%), skin irritation (1% to 2%), sunburn (1% to 2%) ?1%, postmarketing, and/or case reports: Acne flare, angioedema (gel), application site pain (gel), conjunctivitis, contact dermatitis, dermatitis, eczema, eyelid edema, facial edema (gel), skin discoloration, skin rash (cream/gel), swelling of lips (gel) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

